MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aprovel 150mg tablets (Sanofi).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Aprovel 300mg tablets (Sanofi).

Stability Notes

Protect from moisture. Active substance soluble in water.

Provenance

This compatibility recommendation is derived from Azilect 1mg tablets (Teva UK Ltd).

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

Store in airtight containers.

Provenance

This compatibility recommendation is derived from Tramacet 37.5mg/325mg tablets (Grunenthal Ltd).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Molipaxin 100mg capsules (Zentiva Pharma UK Ltd) and Trazodone 100mg capsules (Rivopharm (UK) Ltd).

Stability Notes

Store in airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Femara 2.5mg tablets (Novartis Pharmaceuticals UK Ltd).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Molipaxin 50mg capsules (Zentiva Pharma UK Ltd) and Trazodone 50mg capsules (Rivopharm (UK) Ltd).

Stability Notes

Protect from moisture. Protect from light.

Provenance

This compatibility recommendation is derived from Eucreas 50mg/850mg tablets (Novartis Pharmaceuticals UK Ltd).

Stability Notes

Protect from moisture. Protect from light.

Provenance

This compatibility recommendation is derived from Eucreas 50mg/1000mg tablets (Novartis Pharmaceuticals UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zyvox 600mg tablets (Pfizer Ltd).

Stability Notes

There are no stability notes available for this medicine.
Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.